These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17606715)

  • 61. Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients.
    Hofmann HS; Hansen G; Richter G; Taege C; Simm A; Silber RE; Burdach S
    Clin Cancer Res; 2005 Feb; 11(3):1086-92. PubMed ID: 15709175
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report.
    Lee KD; Lee HH; Joo HB; Lee HS; Yu TH; Chang HK; Jeon CH; Park JW
    Anticancer Res; 2006; 26(2B):1513-8. PubMed ID: 16619566
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
    Cheung IY; Cheung NK
    Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer.
    Lin TS; Chiou SH; Wang LS; Huang HH; Chiang SF; Shih AY; Chen YL; Chen CY; Hsu CP; Hsu NY; Chou MC; Kuo SJ; Chow KC
    Oncol Rep; 2004 Oct; 12(4):717-23. PubMed ID: 15375490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer.
    Yanagawa N; Tamura G; Oizumi H; Endoh M; Motoyama T
    Anticancer Res; 2011 Jan; 31(1):171-5. PubMed ID: 21273595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
    Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
    Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
    Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
    Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
    Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Int6 expression can predict survival in early-stage non-small cell lung cancer patients.
    Buttitta F; Martella C; Barassi F; Felicioni L; Salvatore S; Rosini S; D'Antuono T; Chella A; Mucilli F; Sacco R; Mezzetti A; Cuccurullo F; Callahan R; Marchetti A
    Clin Cancer Res; 2005 May; 11(9):3198-204. PubMed ID: 15867213
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G
    Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
    Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
    Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
    Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.
    Kuner R; Muley T; Meister M; Ruschhaupt M; Buness A; Xu EC; Schnabel P; Warth A; Poustka A; Sültmann H; Hoffmann H
    Lung Cancer; 2009 Jan; 63(1):32-8. PubMed ID: 18486272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.
    Marchetti A; Tinari N; Buttitta F; Chella A; Angeletti CA; Sacco R; Mucilli F; Ullrich A; Iacobelli S
    Cancer Res; 2002 May; 62(9):2535-9. PubMed ID: 11980646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
    Brabender J; Metzger R; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
    Carcinogenesis; 2005 Mar; 26(3):525-30. PubMed ID: 15618235
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
    Lin J; Lin L; Thomas DG; Greenson JK; Giordano TJ; Robinson GS; Barve RA; Weishaar FA; Taylor JM; Orringer MB; Beer DG
    Clin Cancer Res; 2004 Sep; 10(17):5708-16. PubMed ID: 15355897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.